Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous autoimmune disorder critically lacking diagnostic biomarkers. Autoantibodies to nodal and paranodal components have been recently described in a small subset of patients. Here, we investigated the diagnostic value of immune reactivity toward the myelin compartment. 94 French CIDP patients were retrospectively studied. The reactivity toward peripheral nerve was investigated. Sural nerve biopsies were examined by electron microscopy and immunofluorescence. 21 patients (22%) and 3 patients (3 %) presented with a strong IgG or IgM reactivity against the myelin compartment, respectively. The clinical, electrophysiological, and morphological features were examined in nine of these patients for whom sural nerve biopsies were available. Seven patients were electrodiagnosed with definite CIDP, one with possible CIDP and one was unclassifiable but sural nerve biopsy argued for CIDP diagnosis. Electron microscopy of sural nerve biopsies demonstrated the presence of macrophage-mediated demyelination restricted to the internode in all nine patients. Immunolabeling for Nav channels, myelin and axonal markers confirmed the presence of segmental demyelination and of remyelination. The nodal and paranodal regions were, however, unaffected in these patients. Nerve conduction studies corroborated the multifocal and segmental profile, and seven patients showed increased duration of proximal (1.5 to 5.1 times) and/or distal (1.2 to 3.4 times) compound muscle action potential in at least two nerves. Antibody- and macrophage-mediated demyelination appear responsible for conduction alterations in CIDP patients and nerve immunostaining assays may serve as supportive diagnostic biomarker.